In our dataset, genomic alterations in TERT and TP53—the 2 most common genes altered in HCC—correlated with higher bTMB, and these were confirmed in the broader laboratory dataset (Fig. 1E). The gene discussed is TP53; the disease is hepatocellular carcinoma.